Icahn Ditches Amylin Suit After Chat With CEO
Activist investor Carl Icahn said Wednesday that he has dropped his suit against Amylin Pharmaceuticals Inc. after a discussion with the company's CEO, ending a dispute that started over the rejection...To view the full article, register now.
Already a subscriber? Click here to view full article